Key Segmentation:
By Nutrition Type
-
Enteral
-
Parenteral
By Cancer Type
-
Head & Neck
-
Gastrointestinal
-
Lung
-
Breast
-
Others
By Distribution Channel
-
Hospital Pharmacies
-
Retail Pharmacies
-
Online Pharmacies
By End User
-
Hospitals
-
Home Care
-
Others
Regional Coverage:
North America
-
United States
-
Canada
Europe
-
Germany
-
United Kingdom
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization:
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Key players include Danone (Nutricia), Fresenius Kabi, Abbott Nutrition, Nestlé Health Science, Otsuka Pharmaceutical Factory and Kate Farms.
Key opportunities include personalized and disease-specific formulas, home care services, online channels and expansion in Asia and other emerging regions.
Rising cancer survivorship and growing recognition of malnutrition as a cause of poor outcomes are the main growth factors, supported by clinical guidelines.
By Nutrition Type, the Enteral segment dominated the market in 2025 with an estimated 73.91% share, supported by its safety, lower cost and ease of use.
North America dominated the market with a share of 39.64% in 2025, driven by advanced cancer centers, strong clinician awareness and established supply.